Notably, β‐Cryptoxanthin inhibits migration and invasion of α7 nAChR‐expressing NSCLC cells through down‐regulation of the AKT/PI3K cascade [69, 136]. The gene discussed is CHRNA7; the disease is non-small cell lung carcinoma.